Sysmex America Provide Early Glimpse of Hematology Instruments at AACC
20 Jul 2012

Sysmex America, Inc. showcase new hematology instruments that will represent 80% of the company’s future product offering at the American Association of Clinical Chemistry (AACC) meeting in Los Angeles.

The Sysmex® XN-Series* Hematology Analyzers enable laboratories of any size to implement advanced clinical parameters, including a new fluorescent platelet channel for Immature Platelet Fraction (IPF) to aid in the differential diagnosis of thrombocytopenia. The scalable, series-wide compact design delivers a smaller footprint that optimizes workflow and transforms productivity. The instruments are built on the concept of Silent Design®, a fusion of product design and technology, developed with the users and their workplace in mind.

The design intent for the Sysmex XN-Series* Hematology Analyzer is to enable clinical laboratories to withstand future medical technologists shortages; and the ability to keep up with workload demands and testing complexity that may accompany an aging population. “The human-centered approach of Silent Design, upon which the Sysmex XN-Series* Hematology Analyzers are built, provides a simplified system of operation and interface based on careful study of laboratory processes, the relationship between the operator and the instrument and how people work. These instruments are truly representative of how Sysmex is resolving current day issues in the clinical laboratory environment while advancing healthcare overall,” said Ralph Taylor, Executive Vice President, Marketing, and Business Development & Medical Affairs, Sysmex America, Inc.

Sysmex Corporation, Kobe, Japan, was awarded the Good Design Gold Award in October 2011 from Japan’s Ministry of Economy, Trade and Industry for its in vitro diagnostic system employing the company’s new Silent Design® concept.


About Sysmex® XN-Series Hematology Analyzers

The Sysmex XN-Series* Hematology Analyzers enable laboratories to implement advanced clinical and operational capabilities. All configurations provide advanced clinical parameters, including NRBCs with every CBC, immature granulocytes with every Diff, RET-He within the reticulocyte profile and an all-new fluorescent platelet channel for IPF to aid in the differential diagnosis of thrombocytopenia. The series-wide compact design delivers a smaller footprint for increased physical productivity. Smaller reagent sizes and concentrated reagents simplify consumable inventory management. Scalable options exist for auto-validation approaches - from onboard decision rules to Sysmex WAM™ middleware. The XN-Series* is also supported by the Sysmex Peak Performance Program, a rich and comprehensive set of systems and resources that work together to ensure the laboratory’s long-term success.

About Silent Design®

The Good Design Gold Award is awarded to 12 Good Design Award recipients whose high-quality designs are deemed particularly outstanding in helping to resolve current-day issues. Sysmex Corporation has incorporated the Silent Design concept into the Sysmex XN-Series* Automated Hematology Analyzers.

The Good Design Award is a Japanese comprehensive design evaluation and commendation system operated since 1998 by the Japan Institute of Design Promotion (JDP). The system has its origins in the "Good Design Selection System" (known as the "G-Mark System") instituted by the Ministry of International Trade and Industry (now, the Ministry of Economy, Trade and Industry) of Japan in 1957. The Good Design Award judging panel includes a 70-member committee of judges made up of designers, architects, editors, and other specialists working at the cutting edge of design.

*Pending FDA 510(K) clearance. Not available for sale in the U.S.

Request Info


Company website

Sysmex